Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients

Tetsuya E. Tanimoto, Takuhiro Yamaguchi, Yuji Tanaka, Akiko Saito, Kinuko Tajima, Takahiro Karasuno, Masanobu Kasai, Kenji Kishi, Takehiko Mori, Nobuo Maseki, Satoko Morishima, Shigesaburo Miyakoshi, Masaharu Kasai, Yuju Ohno, Sung Won Kim, Akihiko Numata, Masahiro Kami, Yoichi Takaue, Shinichiro Mori, Mine Harada

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

A reduced incidence of graft versus host disease (GvHD) has been documented among Japanese allogeneic bone marrow transplantation (BMT) patients, as the Japanese are genetically more homogeneous than western populations. To clarify whether this ethnic difference affects the results of allogeneic peripheral blood stem cell transplantation (PBSCT), we conducted a nationwide survey to compare clinical outcomes of allogeneic PBSCT (n = 214) and BMT (n = 295) from a human leucocyte antigen-identical-related donor in Japanese patients. The cumulative incidence of grades II-IV acute GvHD was 37.4% for PBSCT and 32.0% for BMT. The cumulative incidence of extensive chronic GvHD at 1 year was significantly higher after PBSCT than BMT (42% vs. 27%; P < 0.01). The organ involvement patterns of GvHD were different between the two groups. By multivariate analyses, the incidence of chronic GvHD was significantly increased in PBSCT, whereas the stem cell source did not affect the incidence of acute GvHD, transplant-related mortality, relapse or survival. We concluded that Japanese PBSCT patients have an increased risk of chronic GvHD compared with BMT patients, but the incidence of acute GvHD was still lower than in western populations. Thus, the choice of haematopoietic stem cell source should be considered based on data for individual ethnic populations.

Original languageEnglish
Pages (from-to)480-493
Number of pages14
JournalBritish Journal of Haematology
Volume125
Issue number4
DOIs
Publication statusPublished - May 1 2004

Fingerprint

Peripheral Blood Stem Cell Transplantation
Homologous Transplantation
Graft vs Host Disease
Bone Marrow Transplantation
Tissue Donors
Incidence
Population
HLA Antigens
Hematopoietic Stem Cells
Stem Cells
Multivariate Analysis
Transplants
Recurrence
Survival
Mortality

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients. / Tanimoto, Tetsuya E.; Yamaguchi, Takuhiro; Tanaka, Yuji; Saito, Akiko; Tajima, Kinuko; Karasuno, Takahiro; Kasai, Masanobu; Kishi, Kenji; Mori, Takehiko; Maseki, Nobuo; Morishima, Satoko; Miyakoshi, Shigesaburo; Kasai, Masaharu; Ohno, Yuju; Kim, Sung Won; Numata, Akihiko; Kami, Masahiro; Takaue, Yoichi; Mori, Shinichiro; Harada, Mine.

In: British Journal of Haematology, Vol. 125, No. 4, 01.05.2004, p. 480-493.

Research output: Contribution to journalArticle

Tanimoto, TE, Yamaguchi, T, Tanaka, Y, Saito, A, Tajima, K, Karasuno, T, Kasai, M, Kishi, K, Mori, T, Maseki, N, Morishima, S, Miyakoshi, S, Kasai, M, Ohno, Y, Kim, SW, Numata, A, Kami, M, Takaue, Y, Mori, S & Harada, M 2004, 'Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients', British Journal of Haematology, vol. 125, no. 4, pp. 480-493. https://doi.org/10.1111/j.1365-2141.2004.04943.x
Tanimoto, Tetsuya E. ; Yamaguchi, Takuhiro ; Tanaka, Yuji ; Saito, Akiko ; Tajima, Kinuko ; Karasuno, Takahiro ; Kasai, Masanobu ; Kishi, Kenji ; Mori, Takehiko ; Maseki, Nobuo ; Morishima, Satoko ; Miyakoshi, Shigesaburo ; Kasai, Masaharu ; Ohno, Yuju ; Kim, Sung Won ; Numata, Akihiko ; Kami, Masahiro ; Takaue, Yoichi ; Mori, Shinichiro ; Harada, Mine. / Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients. In: British Journal of Haematology. 2004 ; Vol. 125, No. 4. pp. 480-493.
@article{0130af96a7894d2fab36183c909a1833,
title = "Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients",
abstract = "A reduced incidence of graft versus host disease (GvHD) has been documented among Japanese allogeneic bone marrow transplantation (BMT) patients, as the Japanese are genetically more homogeneous than western populations. To clarify whether this ethnic difference affects the results of allogeneic peripheral blood stem cell transplantation (PBSCT), we conducted a nationwide survey to compare clinical outcomes of allogeneic PBSCT (n = 214) and BMT (n = 295) from a human leucocyte antigen-identical-related donor in Japanese patients. The cumulative incidence of grades II-IV acute GvHD was 37.4{\%} for PBSCT and 32.0{\%} for BMT. The cumulative incidence of extensive chronic GvHD at 1 year was significantly higher after PBSCT than BMT (42{\%} vs. 27{\%}; P < 0.01). The organ involvement patterns of GvHD were different between the two groups. By multivariate analyses, the incidence of chronic GvHD was significantly increased in PBSCT, whereas the stem cell source did not affect the incidence of acute GvHD, transplant-related mortality, relapse or survival. We concluded that Japanese PBSCT patients have an increased risk of chronic GvHD compared with BMT patients, but the incidence of acute GvHD was still lower than in western populations. Thus, the choice of haematopoietic stem cell source should be considered based on data for individual ethnic populations.",
author = "Tanimoto, {Tetsuya E.} and Takuhiro Yamaguchi and Yuji Tanaka and Akiko Saito and Kinuko Tajima and Takahiro Karasuno and Masanobu Kasai and Kenji Kishi and Takehiko Mori and Nobuo Maseki and Satoko Morishima and Shigesaburo Miyakoshi and Masaharu Kasai and Yuju Ohno and Kim, {Sung Won} and Akihiko Numata and Masahiro Kami and Yoichi Takaue and Shinichiro Mori and Mine Harada",
year = "2004",
month = "5",
day = "1",
doi = "10.1111/j.1365-2141.2004.04943.x",
language = "English",
volume = "125",
pages = "480--493",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients

AU - Tanimoto, Tetsuya E.

AU - Yamaguchi, Takuhiro

AU - Tanaka, Yuji

AU - Saito, Akiko

AU - Tajima, Kinuko

AU - Karasuno, Takahiro

AU - Kasai, Masanobu

AU - Kishi, Kenji

AU - Mori, Takehiko

AU - Maseki, Nobuo

AU - Morishima, Satoko

AU - Miyakoshi, Shigesaburo

AU - Kasai, Masaharu

AU - Ohno, Yuju

AU - Kim, Sung Won

AU - Numata, Akihiko

AU - Kami, Masahiro

AU - Takaue, Yoichi

AU - Mori, Shinichiro

AU - Harada, Mine

PY - 2004/5/1

Y1 - 2004/5/1

N2 - A reduced incidence of graft versus host disease (GvHD) has been documented among Japanese allogeneic bone marrow transplantation (BMT) patients, as the Japanese are genetically more homogeneous than western populations. To clarify whether this ethnic difference affects the results of allogeneic peripheral blood stem cell transplantation (PBSCT), we conducted a nationwide survey to compare clinical outcomes of allogeneic PBSCT (n = 214) and BMT (n = 295) from a human leucocyte antigen-identical-related donor in Japanese patients. The cumulative incidence of grades II-IV acute GvHD was 37.4% for PBSCT and 32.0% for BMT. The cumulative incidence of extensive chronic GvHD at 1 year was significantly higher after PBSCT than BMT (42% vs. 27%; P < 0.01). The organ involvement patterns of GvHD were different between the two groups. By multivariate analyses, the incidence of chronic GvHD was significantly increased in PBSCT, whereas the stem cell source did not affect the incidence of acute GvHD, transplant-related mortality, relapse or survival. We concluded that Japanese PBSCT patients have an increased risk of chronic GvHD compared with BMT patients, but the incidence of acute GvHD was still lower than in western populations. Thus, the choice of haematopoietic stem cell source should be considered based on data for individual ethnic populations.

AB - A reduced incidence of graft versus host disease (GvHD) has been documented among Japanese allogeneic bone marrow transplantation (BMT) patients, as the Japanese are genetically more homogeneous than western populations. To clarify whether this ethnic difference affects the results of allogeneic peripheral blood stem cell transplantation (PBSCT), we conducted a nationwide survey to compare clinical outcomes of allogeneic PBSCT (n = 214) and BMT (n = 295) from a human leucocyte antigen-identical-related donor in Japanese patients. The cumulative incidence of grades II-IV acute GvHD was 37.4% for PBSCT and 32.0% for BMT. The cumulative incidence of extensive chronic GvHD at 1 year was significantly higher after PBSCT than BMT (42% vs. 27%; P < 0.01). The organ involvement patterns of GvHD were different between the two groups. By multivariate analyses, the incidence of chronic GvHD was significantly increased in PBSCT, whereas the stem cell source did not affect the incidence of acute GvHD, transplant-related mortality, relapse or survival. We concluded that Japanese PBSCT patients have an increased risk of chronic GvHD compared with BMT patients, but the incidence of acute GvHD was still lower than in western populations. Thus, the choice of haematopoietic stem cell source should be considered based on data for individual ethnic populations.

UR - http://www.scopus.com/inward/record.url?scp=3142724325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142724325&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2004.04943.x

DO - 10.1111/j.1365-2141.2004.04943.x

M3 - Article

C2 - 15142119

AN - SCOPUS:3142724325

VL - 125

SP - 480

EP - 493

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -